Clinical Trials
4 trialsNCT05688306 2023-01-18
To Evaluate Thrombosis Risk in Chemotherapy Patients With Solid Tumors Who Receiving Thrombocytopenia Treatment
Liaoning Cancer Hospital & Institute
Completed
NCT05023837 2022-01-25
Esporta
Hunan Province Tumor Hospital
Completed
NCT02238366 2019-07-25
CHRONOS3
Ipsen
Completed
NCT02154139 2016-02-17
Leuprorelin Acetate SR 11.25 mg for Injection Specified Drug-use Survey "Long-term Use Survey on Premenopausal Breast Cancer Patients (96 Weeks)"
Takeda
Completed